Completed PHASE3 INTERVENTIONAL 3-arm NCT01178788

Progestagens for the Tertiary Prophylaxis of Preterm Delivery (PROTECT)

Progestagens for the Tertiary Prophylaxis of Preterm Delivery in Women With Short Cervix. A Randomized Multicentre Trial

Sponsor: University of Modena and Reggio Emilia

Conditions Neonatal Complications Preterm Delivery

Interventions 17 alpha-hydroxy progesterone caproate Control micronized Progesterone

Updated 5 times since 2017 Last updated: Sep 21, 2016 Started: Feb 28, 2010 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Neonatal Complications and Preterm Delivery, this trial is completed. The trial is conducted by University of Modena and Reggio Emilia and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Modena and Reggio Emilia

Data source: University of Modena and Reggio Emilia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Modena, Italy